Drug Promotion - What We Know, What We Have Yet to Learn - Reviews of Materials in the WHO/HAI Database on Drug Promotion - EDM Research Series No. 032
(2004; 102 pages) Ver el documento en el formato PDF
Índice de contenido
Ver el documentoAcknowledgements
Ver el documentoExecutive summary
Abrir esta carpeta y ver su contenidoIntroduction
Abrir esta carpeta y ver su contenidoReview 1. What attitudes do professional and lay people have to promotion?
Abrir esta carpeta y ver su contenidoReview 2. What impact does pharmaceutical promotion have on attitudes and knowledge?
Abrir esta carpeta y ver su contenidoReview 3. What impact does pharmaceutical promotion have on behaviour?
Cerrar esta carpetaReview 4. What interventions have been tried to counter promotional activities, and with what results?
Ver el documento4.1 Guidelines, codes and regulations for printed and broadcast material
Ver el documento4.2. The ‘Fair Balance’ requirement
Ver el documento4.3 Guidelines for sales representatives
Ver el documento4.4 Guidelines for post-marketing surveillance
Ver el documento4.5 Guidelines on conflict of interest in research
Ver el documento4.6 Guidelines for package inserts and compendia
Ver el documento4.7 Guidelines about gifts
Ver el documento4.8 Guidelines for trainee doctors and for hospitals
Ver el documento4.9 Knowledge of these guidelines and their effect on attitudes
Ver el documento4.10 Education about promotion
Ver el documento4.11 Monitoring/countering promotion
Ver el documento4.12 Research as an intervention
Ver el documentoSummary of conclusions
Ver el documentoDirections for future research
Ver el documentoFinal conclusions
Ver el documentoReferences
 

Directions for future research

There is a need for greater linkage between research, interventions and evaluation is needed. Those planning interventions need to draw on previous research for designing and targeting their programmes. For example, previous reviews have suggested that some doctors rely heavily on promotion, and that their prescribing is also sometimes irrational. Interventions targeted at these doctors are likely to have a greater impact than those targeted at doctors in general, or particularly interventions which include volunteers only (likely to be those who are already sympathetic to rational prescribing messages). Interventions also need to be evaluated, and these evaluations need to be published so that others can learn from them. Reasonable follow-up times are needed, to show whether the effects of interventions persist over time.

Studies are also urgently needed comparing the effect of different regulatory frameworks. Najman et al.’s study205 was the only one included here which did this. Governments and others introducing policies to regulate promotional activities need good evidence of the advantages and drawbacks of different systems.

 

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013